Cefadroxil hydrate | CAS#66592-87-8 | antibiotic

MedKoo Cat#: 584206 | Name: Cefadroxil hydrate

Featured

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Cefadroxil hydrate, also known as Duricef, is an antibiotic effective against pyodermic skin diseases, such as Staphylococcus aureus and Streptococcus pyogenes.

Chemical Structure

Cefadroxil hydrate

CAS#66592-87-8 (hydrate)

Theoretical Analysis

MedKoo Cat#: 584206

Name: Cefadroxil hydrate

CAS#: 66592-87-8 (hydrate)

Chemical Formula: C16H19N3O6S

Exact Mass: 381.0995

Molecular Weight: 381.40

Elemental Analysis: C, 50.39; H, 5.02; N, 11.02; O, 25.17; S, 8.41

Price and Availability

Size	Price	Availability
100mg	USD 250.00	2 Weeks
1g	USD 550.00	2 Weeks
5g	USD 950.00	2 Weeks

Bulk Inquiry

Buy Now

Add to Cart

Related CAS #

50370-12-2 (free acid) 66592-87-8 (hydrate) 42284-83-3 (sodium)

Synonym

Duricef; Cefadroxil; Cefadroxil monohydrate; Bidocel

IUPAC/Chemical Name

5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2R)-amino(4-hydroxyphenyl)acetyl)amino)-3-methyl-8-oxo-, monohydrate, (6R,7R)-

InChi Key

NBFNMSULHIODTC-CYJZLJNKSA-N

InChi Code

InChI=1S/C16H17N3O5S.H2O/c1-7-6-25-15-11(14(22)19(15)12(7)16(23)24)18-13(21)10(17)8-2-4-9(20)5-3-8;/h2-5,10-11,15,20H,6,17H2,1H3,(H,18,21)(H,23,24);1H2/t10-,11-,15-;/m1./s1

SMILES Code

O=C(C(N12)=C(C)CS[C@]2([H])[C@H](NC([C@H](N)C3=CC=C(O)C=C3)=O)C1=O)O.[H]O[H]

Appearance

Solid powder

Purity

>97% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

Soluble in DMSO

Shelf Life

>2 years if stored properly

Drug Formulation

This drug may be formulated in DMSO

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.9001

More Info

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 381.40 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1: Chen X, Loryan I, Payan M, Keep RF, Smith DE, Hammarlund-Udenaes M. Effect of transporter inhibition on the distribution of cefadroxil in rat brain. Fluids Barriers CNS. 2014 Nov 14;11(1):25. doi: 10.1186/2045-8118-11-25. eCollection 2014. PubMed PMID: 25414790; PubMed Central PMCID: PMC4237734. 2: Jin HE, Kim IB, Kim YC, Cho KH, Maeng HJ. Determination of cefadroxil in rat plasma and urine using LC-MS/MS and its application to pharmacokinetic and urinary excretion studies. J Chromatogr B Analyt Technol Biomed Life Sci. 2014 Feb 1;947-948:103-10. doi: 10.1016/j.jchromb.2013.12.027. Epub 2013 Dec 30. PubMed PMID: 24412692. 3: de Waart DR, van de Wetering K, Kunne C, Duijst S, Paulusma CC, Oude Elferink RP. Oral availability of cefadroxil depends on ABCC3 and ABCC4. Drug Metab Dispos. 2012 Mar;40(3):515-21. doi: 10.1124/dmd.111.041731. Epub 2011 Dec 13. PubMed PMID: 22166395. 4: Rahim N, Naqvi SB, Bibi R, Iffat W, Shakeel S, Muhammad IN. Disintegrants combination: development and optimization of a cefadroxil fast disintegrating tablet. Pak J Pharm Sci. 2014 Sep;27(5 Spec no):1467-75. PubMed PMID: 25176230. 5: Posada MM, Smith DE. Relevance of PepT1 in the intestinal permeability and oral absorption of cefadroxil. Pharm Res. 2013 Apr;30(4):1017-25. doi: 10.1007/s11095-012-0937-8. Epub 2012 Dec 7. PubMed PMID: 23224978; PubMed Central PMCID: PMC3596500. 6: Kim YC, Kim IB, Noh CK, Quach HP, Yoon IS, Chow ECY, Kim M, Jin HE, Cho KH, Chung SJ, Pang KS, Maeng HJ. Effects of 1α,25-dihydroxyvitamin D3 , the natural vitamin D receptor ligand, on the pharmacokinetics of cefdinir and cefadroxil, organic anion transporter substrates, in rat. J Pharm Sci. 2014 Nov;103(11):3793-3805. doi: 10.1002/jps.24195. Epub 2014 Sep 29. PubMed PMID: 25266751. 7: Huh Y, Keep RF, Smith DE. Impact of lipopolysaccharide-induced inflammation on the disposition of the aminocephalosporin cefadroxil. Antimicrob Agents Chemother. 2013 Dec;57(12):6171-8. doi: 10.1128/AAC.01497-13. Epub 2013 Sep 30. PubMed PMID: 24080658; PubMed Central PMCID: PMC3837920. 8: Posada MM, Smith DE. In vivo absorption and disposition of cefadroxil after escalating oral doses in wild-type and PepT1 knockout mice. Pharm Res. 2013 Nov;30(11):2931-9. PubMed PMID: 23959853; PubMed Central PMCID: PMC3844101. 9: Rahim N, Naqvi SB, Shakeel S, Iffat W, Muhammad IN. Determination of Cefadroxil in Tablet/Capsule formulations by a validated Reverse Phase High Performance Liquid Chromatographic method. Pak J Pharm Sci. 2015 Jul;28(4):1345-9. PubMed PMID: 26142506. 10: Mansour NO. Pharmacokinetics and Bioequivalence Evaluation of 2 Cefadroxil Suspensions in Healthy Egyptian Male Volunteers. Clin Pharmacol Drug Dev. 2012 Jul;1(3):110-3. doi: 10.1177/2160763X12449010. PubMed PMID: 27121338. 11: Kemperman GJ, Zhu J, Klunder AJ, Zwanenburg B. Clathration-induced asymmetric transformation of cefadroxil. Org Lett. 2000 Sep 7;2(18):2829-31. PubMed PMID: 10964376. 12: Lamba G, Aswani V. A severe laryngeal angioedema reaction from cefadroxil in a patient with no known allergies to penicillins. West Indian Med J. 2011 Jun;60(3):346-8. PubMed PMID: 22224351. 13: Smith DE, Hu Y, Shen H, Nagaraja TN, Fenstermacher JD, Keep RF. Distribution of glycylsarcosine and cefadroxil among cerebrospinal fluid, choroid plexus, and brain parenchyma after intracerebroventricular injection is markedly different between wild-type and Pept2 null mice. J Cereb Blood Flow Metab. 2011 Jan;31(1):250-61. doi: 10.1038/jcbfm.2010.84. Epub 2010 Jun 23. PubMed PMID: 20571525; PubMed Central PMCID: PMC2965812. 14: Vila Jato JL, Concheiro A, Llabrés M, Alonso MJ. [Oral bioavailability of cefadroxil: influence of food]. Arch Farmacol Toxicol. 1982 Dec;8(3):171-8. Spanish. PubMed PMID: 7183247. 15: Dixit RB, Uplana RA, Patel VA, Dixit BC, Patel TS. Development and evaluation of cefadroxil drug loaded biopolymeric films based on chitosan-furfural schiff base. Sci Pharm. 2010 Oct-Dec;78(4):909-25. doi: 10.3797/scipharm.0912-20. Epub 2010 Sep 26. PubMed PMID: 21179325; PubMed Central PMCID: PMC3007606. 16: Auda SH, Knütter I, Bretschneider B, Brandsch M, Mrestani Y, Große C, Neubert RH. Effect of Different Metal Ions on the Biological Properties of Cefadroxil. Pharmaceuticals (Basel). 2009 Dec 15;2(3):184-193. PubMed PMID: 27713232; PubMed Central PMCID: PMC3978541. 17: Philip AK, Philip B. Phase transited and vapor-induced dual capsular system (DCS) for achieving delayed and osmotic release of cefadroxil. Pharm Dev Technol. 2011 Oct;16(5):457-65. doi: 10.3109/10837450.2010.485321. Epub 2010 May 20. PubMed PMID: 20482448. 18: Rahim N, Naqvi SB, Alam M, Rasheed A, Khalique UA. Comparative bioavailability and pharmacokinetic study of Cefadroxil capsules in male healthy volunteers of Pakistan. Pak J Pharm Sci. 2016 Mar;29(2):453-9. PubMed PMID: 27087092. 19: Esumi Y, Otsuki T, Nanpo T. [Studies on absorption, distribution and excretion of cefadroxil (author's transl)]. Jpn J Antibiot. 1979 Dec;32(12):1350-5. Japanese. PubMed PMID: 529419. 20: Auda SH, Mrestani Y, Ahmed AM, Neubert RH. Characterization of the interaction of cefadroxil with different metal ions using CE. Electrophoresis. 2009 Mar;30(6):1066-70. doi: 10.1002/elps.200800436. PubMed PMID: 19229848.